Evaluation of Event Risks of Cerebro- and Cardiovascular Diseases by Focusing on the Profile of Atherogenic Lipoproteins Developing Atherosclerotic Plaque, not the Value of Lipids
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.